Calls
1
u/AceTrentura
Reddit r/wallstreetbets
Win Rate
100.0%
return
+181.7%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 14
$3.01
+181.7%
The author has held IBRX for a long time, citing strong research and development and a capable CEO. The catalyst is FDA approval of its bladder cancer treatment in Saudi Arabia, with major price moves in the last week. The author notes the stock is very news-dependent, having previously run from about $7 to $45 quickly.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/AceTrentura has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: IBRX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
